…is a poor surrogate for the hemodynamic significance of a coronary lesion, with anatomic and functional assessment discordant in a substantial minority of intermediate lesions…

…of functional severity. Angiographic interpretation is affected by interobserver variability, and the relationship between diameter stenosis and haemodynamic significance is weak, particularly for intermediate lesions…

…patients with intermediate lesions that do not produce physiologically significant flow limitation. The mechanisms are incompletely defined. Proposed contributors include hypercontractility or hypersensitivity of coronary…

…ability is less robust in CABG treated patients, as surgery can bypass complex lesions irrespective of their angiographic complexity. Evolution: SYNTAX Score II To address…

…do not always correspond. Visual estimation of luminal narrowing may therefore be insufficient when deciding whether an intermediate lesion should be revascularized. Coronary pressure assessment…

…the combination of symptoms and/or signs of heart failure and a left ventricular ejection fraction (LVEF) of 41–49%. It occupies an intermediate position…

…management of complicated withdrawal varies between regions and units. Follow the local protocol for choice of drug, dosing, route of administration and criteria for intermediate…

…apply to the anti inflammatory effect. They say nothing about the mineralocorticoid effect or about suppression of the HPA axis, where a long half life…

…Indications Evaluation of chest pain with an intermediate pre test probability of coronary artery disease. Assessment of exercise capacity and symptoms in known heart disease…

…intermediate dose Isoproterenol Dopamine, low dose Dobutamine Levosimendan Amrinone Milrinone Nitroglycerin Nitroprusside Figure 1. The approximate position of each drug according to its vasoconstrictor effect…

…a high risk of hypoglycaemia 8–12 mmol/L The critically ill patient in intensive care According to the local protocol Avoid tight targets in…

…al ). Table 1. Singh–Vaughan Williams classification of antiarrhythmic drugs Class Definition Agents Class IA Na + channel blocker with intermediate offset kinetics Ajmaline, Cibenzoline, Disopyramide…

…year risk of bleeding Low risk 0 3 0.8% Intermediate risk 4 2.6% High risk 5 or more 5.8% Interpretation of ATRIA…

…9 1 Low 2.5 2 Intermediate 5.3 3 Intermediate 8.4 4 High 10.4 ≥5 High 12.3 Interpretation of HEMORR₂HAGES score…

…Intermediate low risk PE includes stable patients who are not low risk but have either RV dysfunction or elevated biomarkers, or neither of these abnormalities…

…disease (ASCVD). Atherosclerosis develops through the progressive deposition and retention of LDL C and other apoB containing lipoproteins within the arterial wall. This initiates inflammatory…

…a low to intermediate likelihood of CAD when cardiac troponin and/or the ECG is normal or inconclusive. The principal diagnostic strength of CCTA is…

Cardiology Clinical medicine Definition and Pathophysiology Dietary patterns are the overall combinations of foods habitually consumed rather than isolated nutrients considered independently. For cardiometabolic health…

…<20% Intermediate ≥20% High Management should incorporate the estimated risk, risk enhancing factors and a clinician–patient discussion regarding the expected net benefit of therapy…

…al ). Table 1. Singh–Vaughan Williams classification of antiarrhythmic drugs Class Definition Agents Class IA Na + channel blocker with intermediate offset kinetics Ajmaline, Cibenzoline, Disopyramide…

…intensive care Intermediate–high Stable Yes Raised Admission with monitoring. Be prepared for rescue thrombolysis Intermediate–low Stable One of the two positive Admission Low…

…Interpretation of the CHA₂DS₂ VA score CHA₂DS₂ VA Score Risk Category Annual Stroke Risk (%) 0 Low 0.2 1 Low 0.6 2 Intermediate 2…

…progressive nature of HCM. By combining these factors, the calculator generates a 5 year SCD risk percentage , which helps clinicians stratify patients into low, intermediate…

…intermediate risk, rather than as a universal population screening test. It may also be considered in selected lower risk individuals with a family history of…

…much of the evidence for shortened regimens derives from selected populations, frequently with low or intermediate ischemic risk and under representation of patients with STEMI…

…from injured cardiomyocytes at substantially lower concentrations than earlier generation assays. They can identify troponin concentrations in approximately 50–95% of healthy individuals, whereas sensitive…

…most persuasive when the initial probability is high enough that the result meaningfully increases the likelihood of disease and can justify further investigation or treatment…

…artery segments : RPLB : Posterolateral branch of the right coronary artery (16) Intermediary artery (17) LPLB : Posterolateral branch of the left circumflex artery (18) Coronary artery…